Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
IBM(IBM.US) further bets on cutting-edge technologies such as AI, quantum computing, and increases investment in the Chicago Technology Park, adding 750 new positions.
Rising oil prices weaken the Fed's interest rate cut expectations, pushing US bond yields to their highest level this month.
US Stock Market Move | UBS Group AG (UBS.US) rose more than 3% in the first quarter, with a year-on-year net profit increase of 80%. The company plans to further buy back shares before the end of the year.
IBM(IBM.US) further bets on cutting-edge technologies such as AI, quantum computing, and increases investment in the Chicago Technology Park, adding 750 new positions.
Rising oil prices weaken the Fed's interest rate cut expectations, pushing US bond yields to their highest level this month.
US Stock Market Move | UBS Group AG (UBS.US) rose more than 3% in the first quarter, with a year-on-year net profit increase of 80%. The company plans to further buy back shares before the end of the year.
RECOMMEND
